Visiomed Group SA
PAR:ALVMG
Balance Sheet
Balance Sheet Decomposition
Visiomed Group SA
Visiomed Group SA
Balance Sheet
Visiomed Group SA
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
7
|
7
|
3
|
1
|
7
|
1
|
7
|
2
|
3
|
|
| Cash |
1
|
6
|
6
|
3
|
0
|
6
|
1
|
7
|
2
|
3
|
|
| Cash Equivalents |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
5
|
3
|
1
|
3
|
4
|
2
|
3
|
6
|
4
|
2
|
|
| Accounts Receivables |
3
|
2
|
0
|
1
|
1
|
0
|
0
|
5
|
2
|
1
|
|
| Other Receivables |
1
|
1
|
1
|
2
|
3
|
2
|
2
|
2
|
2
|
1
|
|
| Inventory |
2
|
3
|
3
|
4
|
6
|
3
|
1
|
1
|
1
|
0
|
|
| Other Current Assets |
1
|
1
|
1
|
2
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| Total Current Assets |
10
|
13
|
12
|
13
|
12
|
13
|
5
|
16
|
7
|
5
|
|
| PP&E Net |
0
|
1
|
1
|
1
|
1
|
1
|
0
|
5
|
9
|
5
|
|
| PP&E Gross |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
5
|
9
|
5
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
0
|
1
|
4
|
6
|
2
|
|
| Intangible Assets |
5
|
5
|
5
|
5
|
5
|
1
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
19
|
25
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
19
|
25
|
|
| Total Assets |
15
N/A
|
19
+28%
|
19
+1%
|
20
+4%
|
19
-8%
|
15
-20%
|
6
-60%
|
44
+646%
|
36
-18%
|
37
+1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
3
|
5
|
5
|
8
|
7
|
5
|
4
|
3
|
2
|
|
| Accrued Liabilities |
2
|
1
|
1
|
2
|
5
|
6
|
3
|
2
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Other Current Liabilities |
4
|
2
|
0
|
0
|
3
|
1
|
0
|
14
|
1
|
0
|
|
| Total Current Liabilities |
10
|
6
|
6
|
7
|
15
|
14
|
9
|
20
|
5
|
9
|
|
| Long-Term Debt |
0
|
0
|
3
|
0
|
3
|
3
|
0
|
5
|
6
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
0
|
1
|
1
|
1
|
0
|
3
|
1
|
5
|
1
|
1
|
|
| Total Liabilities |
11
N/A
|
7
-31%
|
11
+55%
|
7
-34%
|
18
+143%
|
20
+9%
|
10
-48%
|
30
+191%
|
12
-61%
|
12
+6%
|
|
| Equity | |||||||||||
| Common Stock |
7
|
14
|
7
|
14
|
7
|
11
|
20
|
1
|
3
|
3
|
|
| Retained Earnings |
5
|
13
|
13
|
26
|
32
|
25
|
31
|
5
|
9
|
9
|
|
| Additional Paid In Capital |
3
|
10
|
15
|
25
|
25
|
8
|
6
|
17
|
30
|
30
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
12
+172%
|
8
-32%
|
13
+55%
|
0
-97%
|
5
N/A
|
4
+14%
|
14
N/A
|
24
+72%
|
24
-1%
|
|
| Total Liabilities & Equity |
15
N/A
|
19
+28%
|
19
+1%
|
20
+4%
|
19
-8%
|
15
-20%
|
6
-60%
|
44
+646%
|
36
-18%
|
37
+1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
1
|
1
|
3
|
14
|
25
|
138
|
294
|
294
|
|